| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |